Cargando…
Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes
BACKGROUND: Biomarkers to monitor disease activity and predict major adverse cardiac events (MACE) in CS have not been described previously. We aimed to identify biomarkers to predict MACE in cardiac sarcoidosis (CS). METHODS: Patients (N=232) diagnosed with CS were retrospectively enrolled. Biomark...
Autores principales: | Kolluri, Nikhil, Schmidt, Tyler J., Elwazir, Mohamed Y., Kapa, Suraj, Abou Ezzeddine, Omar F., Bois, John P., Schirger, John A., Rosenbaum, Andrew N., Cooper, Leslie T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766851/ https://www.ncbi.nlm.nih.gov/pubmed/36791034 http://dx.doi.org/10.36141/svdld.v39i2.11136 |
Ejemplares similares
-
CARDIAC SEQUELAE OF LONG-COVID
por: Howick, James, et al.
Publicado: (2023) -
Evaluation and Catheter Ablation of Ventricular Arrhythmias in Cardiac Sarcoidosis
por: Ezzeddine, Fatima M., et al.
Publicado: (2022) -
Contact Tracing to Manage COVID-19 Spread—Balancing Personal Privacy and Public Health
por: Kapa, Suraj, et al.
Publicado: (2020) -
Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis jiroveci Pneumonia in Immunocompromised Patients
por: Tang, Guoxing, et al.
Publicado: (2021) -
Risk Prediction Model of Early-Onset Preeclampsia Based on Risk Factors and Routine Laboratory Indicators
por: Xue, Yuting, et al.
Publicado: (2023)